Space- and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted α-Particle Therapy With Astatine 211-ParaThanatrace is a research paper published in International Journal of Radiation Oncology*Biology*Physics (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5-T32-EB004311-19
National Institutes of Health National Cancer Institute
Grant: R01-CA-278882
National Institutes of Health National Cancer Institute
Grant: R00CA267560
NCI NIH HHS
Grant: R01 CA278882
National Institutes of Health National Cancer Institute
Grant: R00-CA-267560
NIBIB NIH HHS
Grant: T32 EB004311
FWCI
1.36
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Structural File of Space-and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted α-Particle Therapy With Astatine 211-ParaThanatrace
Structural File of Space-and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted α-Particle Therapy With Astatine 211-ParaThanatrace
Structural File of Space-and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted α-Particle Therapy With Astatine 211-ParaThanatrace